Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
Pol
S
S
Service de Transplantation Rénale, Hôpital Necker, Paris, France.
Saltiel
C
C
Legendre
C
C
Carnot
F
F
Driss
F
F
Berthelot
P
P
Bréchot
C
C
Ruet
C
C
Kreis
H
H
D000328:Adult; D001706:Biopsy; D002353:Carrier State; D002908:Chronic Disease; D004279:DNA, Viral / Q000032:analysis / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008099:Liver / Q000473:pathology; D008297:Male; D010865:Pilot Projects; D013997:Time Factors; D001084:Vidarabine Phosphate / Q000627:therapeutic use*
D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents; D001084:Vidarabine Phosphate